Used as a selective inhibitor of PI3Kγ (phosphoinositide 3-kinase gamma) in research settings, particularly in studies related to inflammation and immune cell signaling. It helps modulate cellular responses involved in inflammatory diseases, making it a valuable tool for investigating potential therapeutic pathways in conditions like arthritis, asthma, and other immune-mediated disorders. Also employed in cancer research due to the role of PI3K signaling in tumor progression, especially in models where immune system interaction with cancer cells is examined. Its application is primarily limited to in vitro and preclinical in vivo studies.